Format

Send to

Choose Destination
J Reprod Med. 2000 Oct;45(10):823-6.

Uterine rupture and dehiscence associated with intravaginal misoprostol cervical ripening.

Author information

1
Department of Obstetrics and Gynecology, Florida Hospital Family Practice Residency, Orlando, USA. dahmd@mpinet.net

Abstract

OBJECTIVE:

To evaluate if the prostaglandin E1 analogue misoprostol, when used as an agent for cervical ripening, is associated with uterine rupture.

STUDY DESIGN:

We performed a two-year retrospective chart review to determine the incidence of uterine rupture in patients with a previous cesarean delivery undergoing cervical ripening or the induction of labor.

RESULTS:

Uterine dehiscence occurred in 1 and uterine rupture occurred in 3 of 48 women with a prior cesarean delivery treated with 50 micrograms doses of intravaginal misoprostol for cervical ripening. Uterine rupture was found in 1 of 89 women who had an oxytocin infusion for induction of labor and none of the 24 patients who received intravaginal prostaglandin E2 placed for cervical ripening.

CONCLUSION:

Intravaginal misoprostol appears to be associated with an increased incidence of uterine rupture when used in patients undergoing a trial of labor after cesarean.

PMID:
11077631
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center